AC Immune ACIU
NASDAQ ACIU
$2.52 +0.05 (+2.05%)
As of: Oct 22, 2026 · 9:52 AM EDT

AC Immune (ACIU) Short-Term Debt repayments (2020)

Updated

Analysis

AC Immune (ACIU) Short-Term Debt repayments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn -
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn 6.45 Bn
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn -
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn -
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn -
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -
10 AC Immune 253.89 Mn -184.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 859,482.91
Mar 31, 2020 -271,901.65
API Access

AC Immune Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=ACIU&period=max&api_key=YOUR_API_KEY